Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection

NCT02359435 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Reverse hybrid therapy
DRUG: Standard triple therapy

Sponsor

Kaohsiung Veterans General Hospital.

Collaborators

[object Object]